552 SUMOylation inhibitor TAK-981 activates NK cells and macrophages via Type I interferon signaling and shows synergistic activity in combination with rituximab and daratumumab in...

by Yuhong Zhang, Akito Nakamura, Keli Song, Stephen Grossman, Kristina Xega, Allison Berger, Gary Shapiro, Dennis Huszar
Published 2020-11-01

The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma

by Jade Lyons Rimmer, Emanuela Ercolano, Daniele Baiz, Mahindra Makhija, Allison Berger, Todd Sells, Steve Stroud, David Hilton, Claire L Adams, C Oliver Hanemann
Published 2020-06-01